BRUGNOLI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 751
EU - Europa 200
AS - Asia 146
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 1.100
Nazione #
US - Stati Uniti d'America 750
IT - Italia 77
CN - Cina 62
SG - Singapore 34
GB - Regno Unito 27
TR - Turchia 21
DE - Germania 18
ID - Indonesia 18
UA - Ucraina 16
BE - Belgio 15
SE - Svezia 14
AT - Austria 10
PL - Polonia 10
VN - Vietnam 6
FI - Finlandia 5
FR - Francia 4
IN - India 2
JP - Giappone 2
AU - Australia 1
EC - Ecuador 1
ES - Italia 1
IE - Irlanda 1
KR - Corea 1
MX - Messico 1
NG - Nigeria 1
NL - Olanda 1
RO - Romania 1
Totale 1.100
Città #
Fairfield 102
Woodbridge 92
Chandler 88
Ann Arbor 68
Ashburn 66
Houston 47
Cambridge 39
Seattle 37
Wilmington 36
Singapore 31
Jacksonville 28
Beijing 22
Ferrara 22
Jakarta 18
Brussels 15
Princeton 14
Izmir 13
Boardman 10
Vienna 10
Warsaw 10
Milan 9
Nanjing 9
Shanghai 9
Morciano Di Romagna 7
San Diego 7
Dong Ket 6
Los Angeles 6
Nanchang 5
Cagliari 4
Cordignano 4
Falls Church 4
Ferrara di Monte Baldo 4
London 4
Shenyang 4
Bremen 3
Des Moines 3
Santa Clara 3
Auburn Hills 2
Changsha 2
Loerrach 2
Monterenzio 2
Muggia 2
New York 2
Norwalk 2
Orange 2
Pozzuoli 2
Redwood City 2
Tianjin 2
Zhengzhou 2
Addison 1
Amsterdam 1
Balasore 1
Bengaluru 1
Bordeaux 1
Dearborn 1
Dublin 1
Edinburgh 1
Eunpyeong-gu 1
Florence 1
Frankfurt am Main 1
Jiaxing 1
Lappeenranta 1
Melbourne 1
Mountain View 1
New Bedfont 1
Pamplona 1
Philadelphia 1
Prescot 1
Quito 1
San Francisco 1
Sanayi 1
Tappahannock 1
Tokyo 1
Trento 1
Vicenza 1
Washington 1
Totale 910
Nome #
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity 195
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 151
Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia 127
Role of LRRK2 in the regulation of dopamine receptor trafficking 121
Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia 112
Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotics-Induced Weight-Gain. 112
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives 49
Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats 47
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease 42
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia 41
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models 41
Novel therapeutic targets in levodopa-induced dyskinesia: in vivo studies in rodent models of Parkinson’s disease 41
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity 33
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia 27
Totale 1.139
Categoria #
all - tutte 6.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020161 0 0 0 26 16 21 17 18 20 17 17 9
2020/2021221 15 15 10 10 13 8 28 16 13 35 39 19
2021/2022129 3 12 10 3 8 13 11 14 7 12 10 26
2022/2023205 17 33 4 27 27 28 13 13 16 0 18 9
2023/202489 9 4 3 6 6 14 4 12 0 2 2 27
2024/202561 7 16 38 0 0 0 0 0 0 0 0 0
Totale 1.139